FDA warns New Manna Food of Guam about tuna salad sandwich HACCP, label, and registration violations.
What happened
FDA inspected New Manna Food's ready-to-eat prepared foods facility, including seafood, in Tamuning, Guam, from February 1, 2023, through February 3, 2023. FDA found no written seafood HACCP plan or hazard analysis for the tuna salad sandwich, walk-in cooler temperatures of 44°F to 48.7°F with no monitoring or alarm, flies in the processing room, and allergen cross-contact risks. A label review found missing allergen, identity, net quantity, manufacturer, ingredient, and nutrition information, and FDA said the facility was not registered.
What FDA found
The company had no written HACCP plan or hazard analysis for its tuna salad sandwich to control histamine, pathogen growth and toxin formation, and undeclared allergens.
21 CFR 123.6(b)The walk-in cooler holding tuna salad ingredients and finished sandwiches was measured at 44°F to 48.7°F, and the company did not monitor or record temperatures or have an alarm.
21 CFR 123.6(b)Sanitation was not monitored well enough: flies landed on bread and food-contact surfaces, and surfaces were wiped with water only between sandwiches, risking allergen cross-contact.
21 CFR 123.11(b)The tuna salad sandwich label did not declare major food allergens including wheat, milk, fish (tuna), and egg.
section 403(w) of the Act [21 U.S.C. § 343(w)]The label also lacked a common or usual name, net quantity, manufacturer name and place of business, ingredient list, and nutrition information.
21 CFR 101.3, 101.7, 101.5, 101.4(a), 101.9The facility was not registered with FDA and did not submit the required qualified facility attestation.
section 415 of the Act [21 U.S.C. § 350d]; 21 CFR Part 1, Subpart H; 21 CFR 117.201
What FDA wants
FDA tells the company to register the facility immediately and to respond in writing within 15 working days with the specific corrective steps taken, related documentation, and steps to prevent recurrence; if corrections cannot be completed in that time, the company must explain the delay and when it will finish.
Who should pay attention
- retailers and distributors selling refrigerated ready-to-eat sandwiches
- commissaries and contract manufacturers making ready-to-eat foods
- quality teams handling HACCP, allergen labels, and FDA registration
This is a summary. Read the original letter on fda.gov.